Design Therapeutics, Inc.
DSGNHealthcare|Biotechnology|US
$10.21
+0.54 (+5.58%)
DCF Value
$0.26
Tangible Book / Share
$3.21
Cash / Share
$3.31
Clinical Trials (135)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06062810 Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms | Breast Cancer | P2P3 | Active | 600 | RCT, Double-blind | Raloxifene - Usual, Raloxifene - Study |
| NCT07033585 Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers | Type 2 Diabetes | P2P3 | Active | 600 | RCT, Double-blind | Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes, China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes |
| NCT01064466 Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms | Small Cell Lung Cancer | P2P3 | Active | 600 | RCT, Double-blind | ETOPOSIDE - Usual, ETOPOSIDE - Study |
| NCT07145333 Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms | SCLC | P2P3 | Active | 600 | RCT, Double-blind | Topotecan - usual, Topotecan - study |
| NCT03348670 Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms | Prostate Cancer | P2P3 | Active | 600 | RCT, Double-blind | Abiraterone - Usual, Abiraterone - Study |
| NCT05987956 Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | P2P3 | Active | 600 | Open-label | ALECENSA - alectinib hydrochloride capsule |
| NCT07024693 DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy | Fuchs Endothelial Corneal Dystrophy, Fuchs | P2 | Recruiting | 70 | Open-label | DT-168 |
| NCT06874010 A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia | Friedreich Ataxia | P1P2 | Recruiting | 20 | Open-label | DT-216P2 |
| NCT06408337 Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate. | Cleft Lip and Palate | P1P2 | Recruiting | 15 | RCT, Open-label | — |
| NCT02403505 Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer | Rectal Cancer | P1 | Active | 20 | Open-label | CEA protein antigen plus BCG Vaccine Mix for percutaneous use |
| NCT06959563 Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV | HPV Infection | Early P1 | Active | 20 | Open-label | 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use |
| NCT02345122 CAMH PARTNERs Integrated Care Study | Depression, Anxiety | N/A | Active | 635 | RCT, Double-blind | — |
| NCT07221747 PathToScale: The PERSIST Trial | Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP | N/A | Recruiting | 9,900 | RCT, Open-label | — |
| NCT07432932 Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients | Sarcoma, Sarcoma, Leiomyo-, Adult | Recruiting | 800 | — | — | |
| NCT07182838 Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix | HIV Infections | Early P1 | Active | 20 | Open-label | HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use |
| NCT03305341 Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix | Covid19 | Early P1 | Active | 20 | Open-label | COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use |
| NCT01849341 Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily | Chronic Obstructive Pulmonary Disease (COPD) | P4 | Completed | 105 | RCT, Single-blind | Roflumilast alternated days, Roflumilast 500 mcg per day |
| NCT02706119 Insulin in Total Parenteral Nutrition | Diabetes Mellitus | P4 | Completed | 163 | RCT, Open-label | Subcutaneous glargine insulin, Regular insulin added to TPN bag |
| NCT01090856 Predilation of Side Branch During Percutaneous Treatment of Bifurcation Lesions With Provisional T Stenting | Coronary Angiography | P4 | Completed | 420 | RCT, Open-label | — |
| NCT03386630 Effects of Analgesics in Cesarean Section Elective | Anesthesia; Functional | P4 | Completed | 66 | RCT, Open-label | Hyperbaric bupivacaine+Sufentanil, Hyperbaric bupivacaine+Morphine |
| NCT01876407 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer | Oral Mucositis | P4 | Unknown | 126 | RCT, Open-label | — |
| NCT03520959 A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) | Synovial Sarcoma, Cancer | P3 | Terminated | 1 | RCT, Double-blind | LV305, G305 |
| NCT03174522 The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM | Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM) | P3 | Terminated | 49 | RCT, Double-blind | REX-001, Placebo |
| NCT03111238 The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM | Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM) | P3 | Terminated | 3 | RCT, Double-blind | REX-001, Placebo |
| NCT01765842 Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy | Lupus Nephritis | P3 | Terminated | 9 | RCT, Open-label | Rituximab |
| NCT03386656 Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery | Osteoarthritis, Knee | P3 | Completed | 150 | RCT, Double-blind | Amchafibrin |
| NCT01765829 Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis | Psychosis Nos/Other | P3 | Unknown | 104 | RCT, Open-label | Discontinuation antipsychotic treatment, Antipsychotic treatment |
| NCT02565953 Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon | Arteriovenous Fistula Renal Dialysis Devices Obstruction | P3 | Completed | 134 | RCT, Double-blind | — |
| NCT01875263 Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. | Staphylococcus | P3 | Terminated | 1 | RCT, Open-label | Cloxacilin, Cloxacillin, Levofloxacin |
| NCT02022514 Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized. | Coronary Atherosclerosis and Other Heart Disease | P2P3 | Completed | 28 | RCT, Open-label | Conventional medical treatment |
| NCT01761435 Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination | Infection in Solid Organ Transplant Recipients | P3 | Completed | 499 | RCT, Open-label | Influenza vaccine |
| NCT02694146 Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis | Coxarthrosis | P3 | Completed | 74 | RCT, Double-blind | Platelet rich plasma, Hylan G-F 20 |
| NCT02073773 Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke | Ischaemic Stroke | P3 | Completed | 9 | RCT, Single-blind | Levodopa |
| NCT04366323 Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 | Sars-CoV2 | P1P2 | Completed | 26 | RCT, Open-label | ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS |
| NCT01745744 Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients. | Critical Limb Ischemia | P2 | Completed | 33 | RCT, Open-label | — |
| NCT02033278 Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure. | Idiopathic Dilated Cardiomyopathy | P2 | Terminated | 27 | RCT, Double-blind | Infusion of autologous mononuclear bone marrow cells, Placebo infusion |
| NCT01765244 Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment | Severe Trophic Corneal Ulcers Refractory to Conventional Treatment, Sequelae of Previous Trophic Corneal Ulcers | P1P2 | Completed | 16 | RCT, Open-label | Anterior lamellar nanostructured artificial human cornea. |
| NCT02287974 Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin | Critical Limb Ischemia (CLI) | P1P2 | Terminated | 20 | RCT, Open-label | Stem cell infusion |
| NCT02290041 Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response | Discordant Immunological Response in HIV Infected Subjects | P1P2 | Completed | 5 | RCT, Double-blind | Infusion of MSC, Infusion of placebo |
| NCT02290886 A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral | Amyotrophic Lateral Sclerosis | P1P2 | Completed | 52 | RCT, Double-blind | Intravenous administration of 1 million of MSC, Intravenous administration of 2 million of MSC, Intravenous administration of 4 million of MSC |
| NCT01222039 Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease. | Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease | P1P2 | Completed | 19 | RCT, Open-label | — |
| NCT02609984 Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) | Sarcoma, Myxoid/Round Cell Liposarcoma | P2 | Terminated | 89 | RCT, Open-label | CMB305, atezolizumab |
| NCT04366245 Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | SARS-CoV 2 | P1P2 | Completed | 72 | RCT, Open-label | Hyperimmune plasma, Standard of care for SARS-CoV-2 infection |
| NCT02501473 Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142) | Follicular Low Grade Non-Hodgkin's Lymphoma | P1P2 | Terminated | 52 | RCT, Open-label | G100, Pembrolizumab, Rituximab |
| NCT00987363 Intraarterial Infusion of Autologous Bone Marrow in Diabetic Patients With Chronic Ischemia of Lower Limbs (CLI) no Revascularization | Critical Limb Ischemia (CLI), Diabetic Foot | P1P2 | Completed | 60 | RCT, Open-label | — |
| NCT05934825 Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa | Hidradenitis Suppurativa | P1P2 | Unknown | 30 | RCT, Double-blind | Injectable suspension of allogeneic adult mesenchymal stem cells |
| NCT02292628 Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence | Faecal Incontinence | P1P2 | Completed | 16 | RCT, Double-blind | Infusion of mesenchymal stem cells from adipose tissue |
| NCT01454323 Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction. | Chronic Myocardial Ischemia | P2 | Completed | 20 | Open-label | — |
| NCT01408381 Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI). | Critical Limb Ischemia (CLI) | P2 | Completed | 38 | RCT, Open-label | — |
| NCT02406781 Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial | Sarcoma | P2 | Completed | 129 | Open-label | Combination of MK3475 with Metronomic CP, Combination of MK3475 with Metronomic CP and G100 |
| NCT01745783 Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis | Multiple Sclerosis | P1P2 | Completed | 26 | RCT, Double-blind | — |
| NCT00629096 Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy | Dilated Cardiomyopathy | P2 | Completed | 27 | Open-label | — |
| NCT01257776 Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients | Critical Limb Ischemia (CLI), Diabetes | P1P2 | Completed | 33 | RCT, Open-label | Autologous adipose derived mesenchymal stem cells |
| NCT00883584 IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study | Chronic Obstructive Pulmonary Disease | P2 | Unknown | 50 | RCT, Double-blind | IMD-1041, Placebo |
| NCT05234658 Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery | Basal Cell Carcinoma | P2 | Unknown | 21 | RCT, Open-label | PHITAH, PHIT, Skin Autograft |
| NCT01954927 Pain Management in Children and Young Adults With Sickle Cell Disease | Sickle Cell Disease | P2 | Completed | 90 | RCT, Double-blind | Gabapentin, Placebo |
| NCT01056471 Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis | Autoimmune Diseases, Immune System Diseases | P1P2 | Completed | 30 | RCT, Double-blind | — |
| NCT00872326 Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia | Peripheral Vascular Diseases, Diabetic Foot | P1P2 | Completed | 20 | Open-label | — |
| NCT01745731 Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration | Liver Transplant Rejection | P2 | Completed | 13 | RCT, Open-label | — |
| NCT05962931 Clinical Trial With Adipose Tissue Stem Cells on Biological Matrix for the Treatment of Venous Ulcer of the Lower Limbs | Venous Ulcer | P1P2 | Unknown | 20 | RCT, Open-label | Bioengineered Artificial Mesenchimal Sheet (BAMS) |
| NCT02687646 Clinical Trial With MSC for Graft Versus Host Disease Treatment | Acute Graft Versus Host Disease | P1P2 | Completed | 16 | Open-label | Adult Allogeneic Mesenchymal cells from adipose tissue. |
| NCT05285540 Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia | Friedreich Ataxia | P1 | Completed | 39 | RCT, Double-blind | DT-216, DT-216 matching Placebo |
| NCT06772870 A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants | Friedreich Ataxia | P1 | Not Yet Recruiting | 36 | RCT, Double-blind | DT-216P2, Saline |
| NCT05573698 Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia | Friedreich Ataxia | P1 | Completed | 32 | RCT, Double-blind | DT-216, Placebo |
| NCT02122861 Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 | Melanoma - Currently Enrolling, Non-small Cell Lung Cancer - Enrollment Completed | P1 | Completed | 47 | Open-label | ID-LV305 |
| NCT02387125 Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 | Sarcoma, Melanoma | P1 | Terminated | 79 | Open-label | CMB305, G100, Metronomic CPA |
| NCT04222985 Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2 | Genital Herpes | P1 | Terminated | 24 | RCT, Double-blind | HSV 2 Formulation 1, HSV 2 Formulation 2, HSV 2 Formulation 3, HSV 2 Formulation 4, HSV 2 Formulation 5, HSV 2 Formulation 6, Sodium Chloride 0.9% |
| NCT03621475 Novel Arm Restraint in the Intensive Care Unit | Acute Respiratory Failure | P1 | Completed | 8 | RCT, Open-label | — |
| NCT03419806 Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease | Parkinson Disease | P1 | Completed | 25 | RCT, Open-label | Infudopa i.v., Infudopa s.c., LCIG (Duodopa) |
| NCT01751243 Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies | Transplant-Related Hematologic Malignancy | P1 | Withdrawn | — | Open-label | — |
| NCT01397604 The Effects of GLA on Human Volunteers | Healthy Volunteers | P1 | Completed | 32 | RCT, Double-blind | GLA-AF, GLA-SE |
| NCT02015416 A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer | Melanoma, Ovarian Cancer | P1 | Completed | 13 | Open-label | IDC-G305 |
| NCT02303821 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia (ALL) | P1 | Completed | 141 | Open-label | Carfilzomib, Dexamethasone, Mitoxantrone, PEG-asparaginase, Vincristine, Intrathecal (IT) Methotrexate, Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate), 6-Mercaptopurine, Cyclophosphamide, Cytarabine, Daunorubicin |
| NCT02035657 A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma | Merkel Cell Carcinoma | P1 | Completed | 10 | Open-label | GLA-SE |
| NCT06702332 Single Ascending Dose Study of MSD-001 in Healthy Participants | Mental Health Disorders | P1 | Completed | 47 | RCT, Double-blind | MSD-001, Placebo Comparator |
| NCT07797907 This Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer. | Solid Tumor (Phase I) | P1 | Not Yet Recruiting | 110 | Open-label | BD200, BD200 |
| NCT02890121 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: | Systemic Autoimmune Diseases | Completed | 2,006 | — | — | |
| NCT05582720 Cardioprotective Properties of Vegan Burger | Cardiometabolic Health | N/A | Unknown | 15 | RCT, Double-blind | — |
| NCT04301102 The Predict H Trial | Intraoperative Hypotension | N/A | Completed | 80 | RCT, Double-blind | — |
| NCT02890134 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort | Systemic Autoimmune Diseases | Completed | 215 | — | — | |
| NCT04623281 Haemodialysis Outcomes & Patient Empowerment Study 02 | End Stage Renal Disease, Dialysis; Complications | Completed | 20 | — | — | |
| NCT07127133 An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) | Mild Cognitive Impairment (MCI), Dementia | N/A | Not Yet Recruiting | 150 | Open-label | — |
| NCT02521506 Clinical Efficacy of OneTouch® Verio™IQ Meter | Diabetes Mellitus | N/A | Completed | 90 | RCT, Open-label | — |
| NCT04238533 Enhanced Auto-Diagnostic Adaptive Precision Trainer for Myoelectric Prosthetic Users | Amputation | N/A | Unknown | 10 | RCT, Open-label | — |
| NCT02500290 Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet | Acute Coronary Syndrome | Unknown | 2,000 | — | — | |
| NCT02224716 Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals | Community Acquired Pneumonia | Unknown | 968 | — | — | |
| NCT03619382 An Evaluation Of Healthy Ankle Motion And Morphology | Healthy Ankle | Completed | 19 | — | — | |
| NCT06319105 PathToScale: An Implementation Evaluation | Oral Pre-exposure Prophylaxis (PrEP), Long-acting Injectable Cabotegravir for PrEP | Unknown | 9,900 | — | — | |
| NCT04556864 Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19 | Covid19, Hemodynamic Instability | Unknown | 67 | — | — | |
| NCT03253419 HotShOT: Home Safety Occupational Therapy | Hip Replacement | N/A | Withdrawn | — | Open-label | — |
| NCT00685555 Healthy Futures Project: A Community Based Obesity Prevention Program | Overweight, Obesity | Early P1 | Completed | 1,300 | RCT, Open-label | — |
| NCT04262401 Promoting Healthy Habits in Metabolic Syndrome | Metabolic Syndrome | N/A | Unknown | 424 | RCT, Open-label | — |
| NCT03727373 Qualitative Study for Pain Measurement Using Innovative Health Technology | Pain Measurement, Pain, Chronic | Completed | 8 | — | — | |
| NCT01971762 Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology | Staphylococcus Aureus Bacteremia | Completed | 600 | — | — | |
| NCT06124625 Effects of Rehabilitation Combined With a Maintenance Program Compared to Rehabilitation Alone in Post-COVID-19 | Post-COVID-19 Syndrome | N/A | Completed | 90 | RCT, Single-blind | — |
| NCT03072472 BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities | Colorectal Neoplasms, Colonic Polyp | N/A | Completed | 3,221 | RCT, Single-blind | — |
| NCT04475718 Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women | Pregnancy Related, Postpartum Sadness | N/A | Completed | 87 | Open-label | — |
| NCT02379728 Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth | Sleep, Pregnancy | N/A | Completed | 200 | RCT, Double-blind | — |
| NCT02004379 Register of Telaprevir and Boceprevir in Routine Clinical Practice | Hepatitis C | Completed | 1,553 | — | — | |
| NCT03018717 Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases | Chronic Lung Disease, Chronic Heart Disease | N/A | Unknown | 510 | RCT, Open-label | — |
| NCT04462679 COMMIT HIV Trial Nepal | Hiv | N/A | Unknown | 86 | Open-label | — |
| NCT04003779 Reconfiguring the Patient Room to Increase Patient Stability | Elderly, Frail, Accidental Falls | N/A | Completed | 18 | Open-label | — |
| NCT02983994 Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma | Asthma | Completed | 64 | — | — | |
| NCT07545928 Single Arm, Monocentric, Pilot Feasibility Study on an Interactive Virtual Reality Program in 20 Complex In-clinic Palliative Care Patients | Palliative Care, Refractory Pain | N/A | Not Yet Recruiting | 20 | Open-label | — |
| NCT01877902 Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System | Carcinoma, Non-Small-Cell Lung | Unknown | 190 | — | — | |
| NCT05723822 Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments | Mild Cognitive Impairment, Cognitive Decline | N/A | Completed | 12 | Open-label | — |
| NCT04067622 Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment | Acute Respiratory Failure, Encephalopathy | N/A | Completed | 58 | RCT, Open-label | — |
| NCT02890147 Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control | Healthy Subjects | Completed | 649 | — | — | |
| NCT07898280 Smartphone-Based Self-Registration of Health Data in Patients With Severe Unspecific Symptoms or Cancer of Unknown Primary | Advanced Unspecific Symptom, Cancer of Unknown Primary Site | N/A | Not Yet Recruiting | 200 | RCT, Open-label | — |
| NCT03139955 Bodytrak® Feasibility Study | Monitoring, Physiologic, Vital Signs | Unknown | 8 | — | — | |
| NCT02005159 Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae | Bacteremia by Enterobacteriaceae | Completed | 1,064 | — | — | |
| NCT01971749 Register of Treatment of Unprotected Left Main Coronary Artery Stenosis in Andalucía | Unprotected Left Main Coronary Artery Stenosis | Unknown | 315 | — | — | |
| NCT06045988 Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease | Alzheimer Disease, Dementia | N/A | Not Yet Recruiting | 100 | Open-label | — |
| NCT02503059 Etanercept Survival in Elderly Population | Psoriasis | Completed | 70 | — | — | |
| NCT07686302 Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise | COPD | N/A | Not Yet Recruiting | 40 | Single-blind | — |
| NCT02377817 Halifax PrenaBelt Trial | Sleep, Pregnancy | N/A | Completed | 23 | RCT, Double-blind | — |
| NCT03326115 Effectiveness of a Peer Visitation Program to Improve Patient Activation and Quality of Life During Amputation Rehabilitation | Amputation | N/A | Unknown | 46 | RCT, Single-blind | — |
| NCT03213327 StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks | Mental Health Disorder | N/A | Completed | 174 | Open-label | — |
| NCT03663816 Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking | Balance | N/A | Completed | 15 | Open-label | — |
| NCT01886144 Effects of Bracing on Knee Osteoarthritis (OA) | Knee Osteoarthritis | Completed | 25 | — | — | |
| NCT02573272 Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors | Epilepsy | Unknown | 204 | — | eslicarbacepine | |
| NCT04510909 COMMIT Depression Trial Nepal | Depression | N/A | Unknown | 86 | Open-label | — |
| NCT06076928 Brain Computer Interface (BCI) Integrated Wearable Hand Robotic Glove System for Upper Limb Stroke Rehabilitation | Stroke | N/A | Completed | 13 | RCT, Single-blind | — |
| NCT03478007 Low-Cost Tool for Compliance and Treatment-Tracking of Low Back Pain Patients | Low Back Pain | N/A | Completed | 119 | RCT, Open-label | — |
| NCT07712549 Interactive Nature-Based Virtual Reality to Reduce Anxiety, Low Mood, and Feelings of Helplessness in Hospitalized Older Adults With Chronic Illness (Zenctuary VR+) | Psychological Distress, Chronic Disease | N/A | Not Yet Recruiting | 100 | RCT, Single-blind | — |
| NCT04740099 Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) | Opioid Use, Opioid-Related Disorders | N/A | Withdrawn | — | RCT, Double-blind | — |
| NCT03169699 Acoustic Analytic Apps for Smart Telehealth Screening - Creating a Big Data | URTI, Cough | Unknown | 600 | — | — | |
| NCT03858595 Optimizing Gestational Weight Gain, Birth Weight and Other Perinatal Outcomes Among Pregnant Women at Risk of Hypertension in Pregnancy | Hypertension, Pregnancy-Induced, Hypertension, Essential Hypertension | N/A | Unknown | 70 | RCT, Open-label | — |
| NCT06296628 Rehabilitation Device for Hand Mirror Therapy | Stroke | N/A | Completed | 10 | RCT, Open-label | — |
| NCT04630288 Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome | Acute Coronary Syndromes | Unknown | 1,900 | — | Clopidogrel, Ticagrelor | |
| NCT02196064 Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort." | Human Immunodeficiency Virus (HIV) Hepatitis C Virus (HCV) Coinfected Subjects | Completed | 519 | — | — | |
| NCT04044261 Study of Evoked Emotional Responses | Emotion, Expressed | N/A | Completed | 100 | Open-label | — |
| NCT07099066 Generation of Cell Banks and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (ALS) (HCD-SLA) | Amyotrophic Lateral Sclerosis (ALS) | Not Yet Recruiting | 50 | — | — | |
| NCT02005146 Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs | Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues | Completed | 86 | — | — | |
| NCT03004391 Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 | Ovarian Cancer | Completed | 25 | — | — |